Form 990 for tax year 2022
Filed by MCLAUGHLIN RESEARCH INSTITUTE FOR BIOMEDICAL SCIENCES.
Totals
- Total revenue
- $2,415,335
- Total expenses
- $4,290,861
- Contributions and grants received
- $1,912,216
- Grants paid
- $48,750
- Program service revenue
- $435,360
- Investment income
- $64,808
- Other revenue
- $2,951
- Total assets, end of year
- $14,106,801
- Total liabilities, end of year
- $243,063
- Net assets or fund balances, end of year
- $13,863,738
- Program services expenses (Part IX)
- $3,792,836
- Management and general expenses
- $266,682
- Fundraising expenses
- $231,343
- Program service expenses (Part III)
- $3,792,836
Program services were 88.4% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$1,439,987
-
1f · All other contributions, gifts and grants
$472,229
-
2a · Program service revenue: CONTRACT RESEARCH
total $435,360 · related or exempt $435,360
-
3 · Investment income
total $214,279 · excluded $214,279
-
7a · Gross sales of assets other than inventory
securities $1,328,222
-
7b · Less cost or other basis and sales expenses
securities $1,477,693
-
7c · Gain or loss
securities -$149,471
-
7d · Net gain or loss
total -$149,471 · excluded -$149,471
-
11a · Other revenue: MISCELLANEOUS
total $2,951 · related or exempt $2,951
-
11e · Other revenue, total
$2,951
Functional expenses
Part IX, the statement of functional expenses.
-
2 · Grants to domestic individuals
total $48,750 · program services $48,750
-
5 · Compensation of officers, directors and key employees
total $606,313 · program services $284,079 · management and general $263,821 · fundraising $58,413
-
7 · Other salaries and wages
total $1,503,296 · program services $1,078,781 · management and general $340,898 · fundraising $83,617
-
8 · Pension plan contributions
total $198,175 · program services $126,386 · management and general $57,586 · fundraising $14,203
-
9 · Other employee benefits
total $229,410 · program services $157,089 · management and general $53,257 · fundraising $19,064
-
10 · Payroll taxes
total $167,489 · program services $109,556 · management and general $47,881 · fundraising $10,052
-
11a · Fees: management
total $4,928 · management and general $4,928
-
11c · Fees: accounting
total $297 · management and general $297
-
11f · Fees: investment management
total $76,682 · management and general $76,682
-
11g · Fees: other
total $47,659 · program services $8,775 · management and general $21,243 · fundraising $17,641
-
12 · Advertising and promotion
total $7,376 · management and general $46 · fundraising $7,330
-
13 · Office expenses
total $25,053 · management and general $23,769 · fundraising $1,284
-
14 · Information technology
total $33,355 · management and general $28,963 · fundraising $4,392
-
16 · Occupancy
total $267,339 · management and general $267,339
-
17 · Travel
total $17,336 · program services $12,918 · management and general $327 · fundraising $4,091
-
19 · Conferences, conventions and meetings
total $8,329 · program services $5,029 · management and general $3,300
-
20 · Interest
total $1,836 · management and general $1,836
-
22 · Depreciation, depletion and amortization
total $401,473 · program services $1,260 · management and general $400,213
-
23 · Insurance
total $46,718 · management and general $46,718
-
24a · Other expenses: LAB SUPPLIES AND SERVIC
total $227,978 · program services $227,978
-
24b · Other expenses: ANIMAL CARE SERVICES
total $123,701 · program services $123,701
-
24c · Other expenses: REPAIRS AND MAINTENANCE
total $63,758 · program services $9,956 · management and general $53,802
-
24d · Other expenses: REPAIRS AND MAINTENANCE
total $38,049 · management and general $38,049
-
24e · All other expenses
total $145,561 · program services $1,598,578 · management and general -$1,464,273 · fundraising $11,256
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $660,993 · end of year $192,980
-
3 · Pledges and grants receivable
beginning of year $22,035 · end of year $20,846
-
4 · Accounts receivable
beginning of year $814,319 · end of year $826,127
-
9 · Prepaid expenses and deferred charges
beginning of year $113,805 · end of year $180,354
-
10a · Land, buildings and equipment: cost or other basis
$16,636,174
-
10b · Land, buildings and equipment: accumulated depreciation
$10,724,447
-
10c · Land, buildings and equipment, net
beginning of year $5,984,520 · end of year $5,911,727
-
11 · Investments: publicly traded securities
beginning of year $6,544,067 · end of year $6,864,980
-
12 · Investments: other securities
beginning of year $1,486,108 · end of year $105,475
-
15 · Other assets
beginning of year $4,312 · end of year $4,312
-
17 · Accounts payable and accrued expenses
beginning of year $67,372 · end of year $33,918
-
19 · Deferred revenue
beginning of year $55,292 · end of year $25,260
-
23 · Secured mortgages and notes payable
beginning of year $24,607 · end of year $0
-
25 · Other liabilities
beginning of year $192,731 · end of year $183,885
-
27 · Net assets without donor restrictions
beginning of year $11,576,169 · end of year $10,497,153
-
28 · Net assets with donor restrictions
beginning of year $3,713,988 · end of year $3,366,585
Mission and programs · 2022
Mission
THE INSTITUTE'S MISSION IS TO IMPROVE HUMAN HEALTH THROUGH INNOVATIVE GENETIC RESEARCH AND EDUCATION. RESEARCH AT THE INSTITUTE FOCUSES ON UNDERSTANDING THE GENETIC CONTROL OF NORMAL DEVELOPMENT AND SUSCEPTIBILITY TO NEUROLOGICAL DISEASES USING THE MOUSE AS THE MODEL SYSTEM. THE INSTITUTE ALSO OFFERS RESEARCH INTERNSHIPS FOR STUDENTS AND TEACHERS.
Activities or mission (Part I)
THE INSTITUTE'S MISSION IS TO IMPROVE HUMAN HEALTH THROUGH INNOVATIVE GENETIC RESEARCH AND EDUCATION.
-
DURING FISCAL YEAR 2023, THE INSTITUTE SCIENTISTS AND STAFF CONTINUED THEIR EFFORTS TO BETTER UNDERSTANDING THE CELLULAR AND MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASE PROCESSES THROUGH INNOVATIVE GENETIC APPROACHES IN MURINE MODELS WHILE EXPANDING THE PROGRAM OF TRANSLATIONAL RESEARCH TO SUPPLEMENT TREATMENT ADVANCES AND EDUCATION THROUGH COMMUNITY ENGAGEMENT WITH STUDENT INTERNSHIPS. WITH CONTRIBUTIONS RECEIVED THE PREVIOUS YEAR, THE INSTITUTE WAS ABLE TO HIRE TWO ADDITIONAL SCIENTISTS. EXPANDED SCIENTIFIC EMPLOYMENT LED TO EXPANDED RESEARCH TO INCLUDE SUBJECTS OF HUMAN PRIMORDIAL GERM CELLS, MACULAR DEGENERATION, NEUTROPHILS IN AGE RELATED DISEASES, AND NOVEL ASSAY OPTIMIZATION FOR THE IMPROVED DIAGNOSTICS OF NEURODEGENERATIVE DISEASES. FURTHER RESEARCH ON THE EMPHASIS OF GENETIC SUSCEPTIBILITY; CELLULAR MECHANISM COMPONENTS OF PROTEIN MISFOLDING PROPAGATION; IDENTIFICATION OF BIOMARKERS; THE ROLE OF MICROBIOME AND INFLAMMATION; AND CELLULAR SENESCENCE IN DISEASES SUCH AS FRONTOTEMPORAL DEMENTIA, ALZHEIMER'S AND PRION DISEASES, AS WELL AS NOVEL TREATMENT APPROACHES. SUCH WORK INCLUDED PARTNERSHIPS WITH UP TO TEN COLLABORATORS AND 24 PROJECTS AMONG INVESTIGATORS WITH PARTNERSHIPS EXTENDING NATIONALLY TO NEW YORK, MASSACHUSETTS, NORTH CAROLINA, WASHINGTON STATE AND CALIFORNIA WHICH RESULTANT SUBAWARDS CONTRIBUTED TO $413,000 OF NIH GRANT FUND SUPPORT AND $430,000 IN RESEARCH CONTRACTS. EFFORTS CONTINUED TOWARDS UNDERSTANDING HUNTINGTON'S DISEASE IN COLLABORATION WITH INVESTIGATORS FROM WESTERN WASHINGTON UNIVERSITY AND THE CURE HUNTINGTON'S DISEASE FOUNDATION; ALZHEIMER'S DISEASE WITH PARTNERS AT COLUMBIA UNIVERSITY AND WAKE FOREST UNIVERSITY; AS WELL AS MAKING STRIDES ON INVESTIGATOR LED STUDIES AND FUTURE FUNDING OPPORTUNITIES WITH THE NATIONAL INSTITUTES OF HEALTH. INVESTIGATORS CONTINUED CRITICAL WORK WITH NEW TREATMENT DEVELOPMENT SCREENING THROUGH ONGOING COLLABORATION WITH PHARMACEUTICAL COMPANIES AND WELCOMED NEW COLLABORATIONS WITH CUREDRPLA AND N-LOREM. THE INSTITUTE CONTINUED THE EFFORTS OF THE NIH FUNDED GRANT (AWARDED MARCH 2018) IN THE AMOUNT OF $405,000/YEAR FOR FIVE YEARS DIRECTED TOWARDS BETTER UNDERSTANDING OF ELECTROPHYSIOLOGY OF NEUROTRANSMITTERS IN NEURODEGENERATIVE DISEASES WITH THE FINAL YEAR IN COMPLETED ON A NO COST EXTENSION. NIH AWARD OF $360,306 WAS RECEIVED FOR DISSECTION OF THE TRANSCRIPTIONAL NETWORKS OF HUMAN PRIMORDIAL GERM CELLS AND $292,000 FOR AGE RELATED MACULAR DEGENERATION RESEARCH. THE INSTITUTE RECEIVED $457,000 IN CONTRIBUTIONS THAT WAS USED TO SUPPORT INVESTMENTS FOR FUTURE RESEARCH AND EDUCATION.
Expenses $3,744,086 · Revenue $438,311
-
Withheld by Nonprofiteer: this text may name a private individual.
Expenses $48,750 · Grants $48,750
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.
Listed in Part VII
-
Randy GrayRANDY GRAY
CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Maxon DavisMAXON DAVIS
VICE-PRESIDENT
- Total calculated
- $0
- Hours/week
- 1
-
Bjarne JohnsonBJARNE JOHNSON
SECRETARY
- Total calculated
- $0
- Hours/week
- 1
-
Gary BjellandGARY BJELLAND
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
David Cameron PhDDAVID CAMERON PHD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
George A Carlson PhDGEORGE A CARLSON PHD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Paul EichwaldPAUL EICHWALD
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
John LaneJOHN LANE
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Erik SlettenERIK SLETTEN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Cathie TronsonCATHIE TRONSON
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Dr Irving WeissmanDR IRVING WEISSMAN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Arlyne ReichertARLYNE REICHERT
HONORARY BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 1
-
Gene ThayerGENE THAYER
EXECUTIVE BOARD CHAIR
- Total calculated
- $0
- Hours/week
- 1
-
Renee Reijo PeraRENEE REIJO PERA
DIRECTOR/CURRENT PRESIDENT
- Total calculated
- $258,749
- From this org
- $222,357
- From related orgs
- $0
- Other
- $36,392
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $222,357
- Bonus
- $0
- Other
- $0
- Deferred
- $22,525
- Nontaxable benefits
- $13,867
- Filer's total
- $258,749
-
Meganne CaseyMEGANNE CASEY
CURRENT VP OPERATIONS
- Total calculated
- $115,532
- From this org
- $105,032
- From related orgs
- $0
- Other
- $10,500
- Hours/week
- 40
-
Deborah CabinDEBORAH CABIN
CURRENT VICE PRESIDENT
- Total calculated
- $139,601
- From this org
- $119,701
- From related orgs
- $0
- Other
- $19,900
- Hours/week
- 40
-
Teresa GunnTERESA GUNN
ASSOCIATE PROFESSOR
- Total calculated
- $140,767
- From this org
- $120,750
- From related orgs
- $0
- Other
- $20,017
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
LEWIS AND CLARK BIOLOGICALS INC
C · SALES - MISCELLANEOUS · MT · 100% owned
Directly controlled by MCLAUGHLIN RESEARCH
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 17 November 2025
- IRS schema version
- 2022v5.0
- Source object
- 202513219349310346
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.